CME: Beneath the Surface: Psoriatic Arthritis in Dermatology Practice

Be part of the knowledge.

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Beneath the Surface: Psoriatic Arthritis in Dermatology Practice

Beneath the Surface: Psoriatic Arthritis in Dermatology Practice
Get an in-depth look into the role dermatology providers play in identifying and managing psoriatic arthritis.

Available credits: 0.50


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Untreated psoriatic arthritis leads to irreversible joint damage. However, most people with psoriatic arthritis experience multiple symptoms over a period of years before they are properly diagnosed. Dermatology providers are at the front lines, making a psoriatic arthritis diagnosis and helping to prevent joint destruction. Further, there are expanded therapeutic options and growing evidence for choosing optimal therapy for patients with psoriatic arthritis. This interview-style enduring activity features a discussion with a dermatology provider and a rheumatology provider on the role of dermatology providers in identifying and managing of psoriatic arthritis.  

  • Disclosure of Conflicts of Interest

    Educational activities provided by Forefront Collaborative must demonstrate balance, independence, and scientific rigor. All those in a position to control the content of an activity must disclose all relevant financial relationship(s) with commercial interest(s)*. For this educational activity, all conflicts of interest have been resolved through peer review and revisions to ensure independence, evidence base, fair balance, and absence of commercial bias. Disclosures appear below. 

    *The ACCME defines a commercial interest as any entity producing, marketing, reselling, or distributing healthcare goods or services consumed by or used on patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests. 

    The following individuals have indicated that neither they nor their spouses/partners have had, in the past 12 months, financial relationship(s) with commercial interests relative to the content of this CME activity: 

    • Marianna Shershneva, MD, PhD (Planner, Forefront Collaborative)
    • Jessica Porucznik (Planner, Forefront Collaborative)

    The following individuals have disclosed that they and/or their spouse/partner have had a financial relationship in the past 12 months: 

    • Lakshi Aldredge, MSN, ANP-BC (Faculty): Consultant and speaker for AbbVie Inc., Celgene Corporation, Eli Lilly and Company, Novartis, Sanofi, and Regeneron
    • Rebecca Muntean, MD, ND, FACR (Faculty): Speaker for Janssen Pharmaceuticals Inc.
    • Lily Zurkovsky, PhD (Planner, Forefront Collaborative): has personal stock in Teva Pharmaceutical Industries Ltd.

    CME Content Review

    The content of this activity was independently peer reviewed by two reviewers. The reviewers of this activity have no relevant financial relationships to disclose.


  • Target Audience

    The target audience for this educational activity is nurse practitioners and physician assistants who specialize in dermatology. Dermatologists and other clinicians who are members of the healthcare team providing care for patients with psoriasis may benefit from participation in the activity.

  • Learning Objectives

    As a result of participation in this educational activity, participants should be able to:

    1. Screen patients with psoriasis for psoriatic arthritis (PsA) at every visit.
    2. Evaluate laboratory tests and radiographic findings helpful in recognizing PsA.
    3. Explore best practices for dermatology and rheumatology providers in working together to improve timely diagnosis of PsA.
    4. Discuss Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) recommendations for choosing optimal therapy for patients with PsA.
  • Accreditation and Credit Designation Statements

    Forefront Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Credit Designation for Enduring
    Forefront Collaborative designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

    This activity is approved for .50 contact hour(s) of continuing education (which includes .10 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 18043170. This activity was planned in accordance with AANP CE Standards and Policies.

    IPMA is approved by the California Board of Registered Nursing, Provider Number 6971, for .6 contact hours. Each person should retain this certificate for 4 years after the course has been completed. RNs outside of California must verify with their licensing agency for approval of this course.

  • Provider(s)/Educational Partner(s)

    This activity is provided by Forefront Collaborative in collaboration with Interstate Postgraduate Medical Association.

  • Commercial Support

    This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding, visit

  • Disclaimer

    The views and opinions expressed in this activity are those of the faculty and do not necessarily reflect the views or recommendations of Forefront Collaborative, Interstate Postgraduate Medical Association, or Lilly. 

    This continuing medical education activity may include reference(s) to unlabeled or unapproved uses of drugs.


  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.